AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Collection of Blood and Skin Samples From Patients With Primary Mitochondrial Diseases and Healthy Volunteers

Recruitingn/aAges 3 Years - 85 YearsAllMinovia Therapeutics Ltd.
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

Mitochondrial diseases are a genetically diverse group of disorders, some of which are caused by mutations or deletions in the mitochondrial DNA (mtDNA) and which display a wide range of severity and phenotypes. Despite a prevalence of roughly 1 in 8500 in the population there is no effective treatments for the majority of mitochondrial diseases beyond supportive care (Gorman 2016, Elliott 2008). Many of these, such as Pearson syndrome and Kearns-Sayre syndrome, are early onset disorders, and may lead to mortality within the first decades of life. Importantly, mitochondria are selectively inherited from the mother. In addition, there are numerous diseases in which mitochondrial dysfunction plays an important role. Some examples are Alzheimer's and Parkinson's disease, both of which are known to have mitochondrial involvement. Minovia therapeutics develops a therapeutic intervention call

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: 1. Male or female, age 3 to 85 years. 2. For patients with Primary Mitochondrial Disease: a. Clinical diagnosis of PMD confirmed by mtDNA sequencing. 3. For Healthy Volunteers: 1. Normal Vital signs and BMI for age 2. No active medical conditions or diseases 3. No current medications, other than acetaminophen and naproxen sodium 4. For All Subjects: 1. No viral or bacterial illness in past 2 weeks 2. No antibiotic or antiviral medications in past 2 weeks 3. No blood transfusion in past 2 weeks 4. No current pregnancy 5. Not currently breastfeeding 6. Alcohol use less than 2 drinks / day 7. No recreational or illicit drug use in previous 1 year 8. No tobacco or nicotine containing products in previous 1 year 5. Patient, parent or guardian able to understand and provide voluntary written informed consent. Exclusion Criteria: 1\. History of prior treatment with allogeneic hematopoietic stem cell transplantation, or gene therapy.
๐Ÿ’Š

What it tests

  • Not listed
๐Ÿ“

Where

1 site
Sheba Medical Center - Tel Ashomer
Ramat Gan, Israel
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy